Pharma Pulse: FDA Approval of Leucovorin Calcium for CFD and Persistent Inequities in OTC Naloxone Access

In today’s Pharma Pulse, the FDA approved Wellcovorin as the first therapy for an
ultra-rare neurological disorder, and disparities in OTC naloxone access persist despite declining retail prices.